The full-year revenue was a 2 percent increase from $421 million in 2019, the release said. Total revenue includes net product sales of Exparel and Iovera.
Highlights from Pacira’s fourth quarter include $125.3 million in net sales for Exparel and $22.4 million for Iovera, the release said. The company also saw $1.2 million in royalty revenue in 2020.
Read more details and figures from the fourth quarter here.
More articles on devices:
HOPCo, Ascension joint venture spine hospital opens in Florida; Georgia expansion planned
Stryker makes 1st acquisition of 2021: 4 details
As bundle participation declines, orthopedics looks to increased risk sharing and population health
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.